ZOLADEX 3.6 MG INJECTION
| Brand Name | Zoladex |
| Dosage Form | Injection/Implant |
| Strength | 3.6 mg |
| Active Ingredient | Goserelin Acetate |
| Route of Administration | Subcutaneous |
| Therapeutic Class | Hormonal Therapy / LHRH Agonist |
| Indications | Prostate cancer, breast cancer, endometriosis, and uterine fibroids |
| Prescription Required | Yes |
| Storage | Store below 25°C; do not freeze |
| Manufacturer | AstraZeneca |
ZOLADEX 3.6 MG INJECTION
Zoladex 3.6 mg Injection contains goserelin acetate, a long-acting hormonal therapy medicine used in the treatment of prostate cancer, breast cancer, endometriosis, and other hormone-dependent conditions. It belongs to the class of gonadotropin-releasing hormone (GnRH) analogues and helps regulate hormone levels involved in disease progression.
Zoladex works by reducing the production of testosterone or estrogen in the body, which plays a key role in slowing the growth of hormone-sensitive tumors and managing gynecological conditions. This targeted hormonal action supports effective disease control when used as part of a prescribed treatment plan.
Administered as a long-acting subcutaneous injection, Zoladex 3.6 Injection provides sustained therapeutic effects with convenient dosing intervals. It is used in hospitals and clinical settings and should be administered strictly by a qualified healthcare professional to ensure safe and effective treatment outcomes.
Product Features
- Contains Goserelin Acetate (LHRH agonist)
- Used in hormone-dependent cancers and gynecological conditions
- Long-acting formulation with monthly dosing
- Helps suppress testosterone or estrogen levels
- Administered as a subcutaneous implant
- Prescription-only medication
How It Helps
- Reduces the production of testosterone or estrogen in the body
- Slows the growth of hormone-dependent cancers
- Helps manage symptoms of endometriosis and related conditions
- Provides sustained hormonal control with long-acting action
Reviews
There are no reviews yet.